Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lightstone Ventures is a global venture capital fund founded in 2012 that specializes in early-stage investments in life sciences, particularly biotech and medtech. The firm partners with visionary founders to translate novel scientific breakthroughs into clinically and commercially meaningful therapies. Its team has been involved with numerous successful exits, including IPOs and acquisitions of leading biopharma and medical device companies such as Acceleron Pharma, ALX Oncology, Calithera Biosciences, Ra Pharmaceuticals, Disarm Therapeutics, and others.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lightstone Ventures.